Barr Seeks To Use Mensing As Shield In Accutane MDL
Barr Laboratories Inc. on Monday argued that failure-to-warn claims from a man diagnosed with inflammatory bowel disease after using generic Accutane are blocked by the U.S. Supreme Court's Pliva Inc. v....To view the full article, register now.
Already a subscriber? Click here to view full article